Nature Medicine - CURRENT ISSUE : July 2008, Volume 14 No 7
LATEST HIGHLIGHTS
NEWS FEATURE
Turning to matchmaking to speed translational research
Report by Meredith WadmanIn May, Harvard Medical School and its affiliated hospitals landed a large grant aimed at hooking up basic and clinical researchers trying to turn lab ideas more quickly into medicines that will help patients.
BLOG
Spoonful of medicine
Our webstats show that many of you are visiting Spoonful of Medicine. Thanks for your support, and please don't forget to give us your feedback on what we post.
NEWS & VIEWS
Trauma therapy on ice
Community cornerCooling the body after brain injury is beneficial in animal models but does not seem to work in children, according to a recent clinical trial. What do the experts think?
NEWS & VIEWS
Cannabinoids keep on giving
Bedside↔BenchThis month in our B2B section, Daniele Piomelli and Beat Lutz & Krisztina Monory discuss two fascinating aspects of rimonabant, the best known antagonist of endocannabinoid signaling.
CURRENT ISSUE
Imatinib buys time for brain after stroke
Article by Su et al.The best drug against stroke, tissue plasminogen activator, must be given soon after injury due to the risk of hemorrhage. The anticancer drug imatinib may help overcome these limitations.
See also:
News and Views by RieckmannCURRENT ISSUE
Rejuvenating premature aging
Letter by Varela et al.Two commonly prescribed drugs, statins and aminobisphosphonates, may be helpful in combating the rare premature-aging disorder, Hutchinson-Gilford progeria syndrome.